VYNE Therapeutics
VYNE
VYNE
105 hedge funds and large institutions have $132M invested in VYNE Therapeutics in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
17% less capital invested
Capital invested by funds: $160M → $132M (-$28M)
Holders
105
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.71M | |
| 2 | +$767K | |
| 3 | +$695K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$608K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$452K |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$2.05M | |
| 3 | -$1.26M | |
| 4 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$1.12M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.09M |